Canaccord Genuity

Hudbay Completes Upsized Bought Deal Equity Offering

Retrieved on: 
fredag, maj 24, 2024
Offering, RBC Capital Markets, News, Indian stock exchange, National Bank of Canada, Bank of America, Exercise, TD Securities, HBM, Sale, BMO Capital Markets, Bank, Form, Constância, ING Group, Barclays, Scotiabank, Canaccord Genuity, TSX, Acceleration, Security (finance)

TORONTO, May 24, 2024 (GLOBE NEWSWIRE) -- Hudbay Minerals Inc. (“Hudbay” or the “Company”) (TSX, NYSE: HBM) is pleased to announce that the Company has closed its previously announced public offering of common shares of the Company (the “Common Shares”).

Key Points: 
  • TORONTO, May 24, 2024 (GLOBE NEWSWIRE) -- Hudbay Minerals Inc. (“Hudbay” or the “Company”) (TSX, NYSE: HBM) is pleased to announce that the Company has closed its previously announced public offering of common shares of the Company (the “Common Shares”).
  • The underwriters exercised the full over-allotment option to purchase an additional 15% of the Common Shares in connection with the Offering.
  • The Company issued, on a bought deal basis, 42,366,000 Common Shares, including 5,526,000 Common Shares pursuant to the exercise of the over-allotment option, at a price of US$9.50 per Common Share for aggregate gross proceeds of US$402,477,000 (the “Offering”).
  • Forward-looking information herein includes, but is not limited to, statements related to the use of proceeds of the Offering and Hudbay’s business, objectives, strategies, and intentions.

Marimaca Hosts Mejillones Open House; Achieves “A” Rating in 2023 Digbee Sustainability Assessment and Provides Corporate Update

Retrieved on: 
onsdag, maj 22, 2024
Partnership, News, National instrument, MOD, TSX, Shelf, Legislation, Distribution, Sale, NOT, Seawater, Intermediary, DFS, Open House, ATM, Toronto Stock Exchange, Mejillones, Treasury, Canaccord Genuity, Copper, Mining, Suite, Groundwater, Bank

VANCOUVER, British Columbia, May 22, 2024 (GLOBE NEWSWIRE) -- Marimaca Copper Corp. (“Marimaca Copper” or the “Company”) (TSX: MARI) is pleased to provide project and corporate updates regarding it’s ongoing development strategy to accelerate the Marimaca Oxide Deposit (the “MOD”) toward first production.

Key Points: 
  • The ATM Program is intended to provide the Company with additional financing flexibility should it be required in the future.
  • The volume and timing of distributions under the ATM Program, if any, will be determined in the Company’s sole discretion.
  • Distributions of the Marimaca Copper Shares under the ATM Program will be made pursuant to the terms and conditions of the Distribution Agreement.
  • Neither the TSX nor the Canadian Investment Regulatory Organization accepts responsibility for the adequacy or accuracy of this release.

TerrAscend Announces May Conference Participation

Retrieved on: 
tisdag, maj 14, 2024
Canaccord Genuity, Fireside chats, TSX, Conference

TORONTO, May 14, 2024 (GLOBE NEWSWIRE) -- TerrAscend Corp. (“TerrAscend” or the “Company”) (TSX: TSND) (OTCQX: TSNDF), a leading North American cannabis operator, today announced that its executive management team will participate in the following upcoming conferences in May.

Key Points: 
  • TORONTO, May 14, 2024 (GLOBE NEWSWIRE) -- TerrAscend Corp. (“TerrAscend” or the “Company”) (TSX: TSND) (OTCQX: TSNDF), a leading North American cannabis operator, today announced that its executive management team will participate in the following upcoming conferences in May.
  • 19th Annual Needham Technology, Media, & Consumer Virtual Conference, May 14-16, 2024: Jason Wild, Executive Chairman, will participate in a virtual Fireside Chat at 3:00 PM ET on May 16th.
  • Canaccord Genuity 8th Annual Global Cannabis Conference, May 23, 2024, in New York City: Jason Wild, Executive Chairman, will participate in a panel discussion titled, “Overview of Emerging US Markets - Ohio, Virginia, Maryland” at 2:15 PM ET.
  • Please reach out to your conference representatives or email [email protected] .

InterCure to Participate in Canaccord Genuity’s 8th Annual Global Cannabis Conference

Retrieved on: 
onsdag, maj 22, 2024
Natural Resources, Pharmaceutical, Other Manufacturing, Health, Other Natural Resources, Cannabis, Manufacturing, Other Health, Canaccord Genuity, Conference, Westin Hotels & Resorts

InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) (dba Canndoc), the leading medical cannabis company outside of North America, today announced that it will participate in the Canaccord Genuity 8th Annual Global Cannabis Conference.

Key Points: 
  • InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) (dba Canndoc), the leading medical cannabis company outside of North America, today announced that it will participate in the Canaccord Genuity 8th Annual Global Cannabis Conference.
  • The conference is scheduled for tomorrow, May 23, 2024, at the Westin NY Grand Central Hotel in New York City.
  • This prestigious event will bring together senior management teams from leading cannabis companies including InterCure CEO Alex Rabinovitch, to engage in panel discussions, fireside chats, and one-on-one meetings.
  • For more information about the event please refer to the following link:

Team Revolution Launches Another Cycling Season to Raise Funds for Humber River Health Foundation

Retrieved on: 
torsdag, maj 9, 2024
City Life (magazine), Canaccord Genuity, TSX, Campari, Toronto Stock Exchange, Lavazza, Divine Bradley, CIBC, Health

The joyous launch event was a celebration of the Team Revolution cyclists who all share two passions, cycling and raising funds for Humber River Health as it continues to innovate and use technology to reinvent patient care.

Key Points: 
  • The joyous launch event was a celebration of the Team Revolution cyclists who all share two passions, cycling and raising funds for Humber River Health as it continues to innovate and use technology to reinvent patient care.
  • "Their commitment extends beyond financial support — they genuinely share our team members' passion for cycling and enhancing health care in our region.
  • "As Board Chair at Humber River Health and a Team Rev rider since the beginning, I see firsthand the impact of these fundraising efforts.
  • "It is also testament to their passion and commitment not only to cycling, but to raising funds for Humber River Health, North America's first digital hospital."

Ascend Wellness Holdings Announces Upcoming Investor Conferences

Retrieved on: 
torsdag, maj 9, 2024
Conference, Canaccord Genuity, Drug

NEW YORK, May 9, 2024 /PRNewswire/ - Ascend Wellness Holdings, Inc. (or "Ascend") (CSE: AAWH-U.CN) (OTCQX: AAWH), a multi-state, vertically integrated cannabis operator, announced today that the Company will participate in the following upcoming conferences:

Key Points: 
  • NEW YORK, May 9, 2024 /PRNewswire/ - Ascend Wellness Holdings, Inc. (or "Ascend") (CSE: AAWH-U.CN) (OTCQX: AAWH), a multi-state, vertically integrated cannabis operator, announced today that the Company will participate in the following upcoming conferences:
    John Hartmann, Chief Executive Officer, will participate in a virtual fireside panel.
  • Canaccord Genuity's 8th Annual Global Cannabis Conference, May 23, 2024:
    John Hartmann will take part in a panel and one-on-one investor meetings at the conference in NYC.
  • Mark Cassebaum, Chief Financial Officer, and Rebecca Conti Koar, Executive Vice President of Investor Relations & Strategy will also participate in one-on-one investor meetings over the duration of the conference.
  • 7th KCSA Virtual Cannabis Conference, June 5, 2024:
    John Hartmann will participate in a virtual fireside chat.

Apollomics Announces Private Placement Financing and Addition to Board of Directors

Retrieved on: 
onsdag, maj 8, 2024
Sale, Genomics, Canaccord Genuity, Proteomics, Security (finance), PIPE, Lawrence Berkeley National Laboratory, APLM

The PIPE financing is expected to close on May 8, 2024, subject to satisfaction of customary closing conditions.

Key Points: 
  • The PIPE financing is expected to close on May 8, 2024, subject to satisfaction of customary closing conditions.
  • Apollomics also announced today the appointment of Dr. Robert (Bob) Lin, M.D., Ph.D. to the board of directors of Apollomics.
  • In addition, Jonathan Wang, Ph.D. has resigned from the board of directors, due to personal reasons.
  • He brings valuable medical and biotech experience to our Board,” said Dr. Guo-Liang Yu, Ph.D., Chairman and Chief Executive Officer of Apollomics.

Trulieve Announces May 2024 Event Participation

Retrieved on: 
tisdag, maj 7, 2024
Canaccord Genuity, River, OTCQX, Conference, Cryptocurrency

TALLAHASSEE, Fla., May 7, 2024 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL ) (OTCQX: TCNNF ) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced planned event participation in May.

Key Points: 
  • TALLAHASSEE, Fla., May 7, 2024 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL ) (OTCQX: TCNNF ) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced planned event participation in May.
  • 19th Annual Needham Technology, Media, & Consumer Conference, May 16, 2024: Christine Hersey, VP of Investor Relations, will participate in virtual meetings on May 16.
  • Canaccord Genuity 8th Annual Global Cannabis Conference, May 23, 2024: Founder and CEO Kim Rivers will participate in a fireside chat and investor meetings.
  • Information about our events, links to events where available, and slide presentations can be found at: https://investors.trulieve.com/events

Seelos Therapeutics Announces Strategic Focus on Mental Health Initiatives and Provides an Update on Current Discussions of Potential Partnerships and Collaborations

Retrieved on: 
måndag, april 29, 2024
Disclosure, Canaccord Genuity, PTSD, Therapy, Government, Mental health, Suicide, Pharmaceutical industry

NEW YORK, April 29, 2024 /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL) ("Seelos"), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today provided an update on the current discussions of potential partnerships and collaborations and announced the appointment of Richard Pascoe as Chairman of the Board of Directors of Seelos to lead the ongoing strategic process and business development discussions and negotiations. Mr. Pascoe has served as member of the Seelos board since 2019.

Key Points: 
  • Mr. Pascoe has served as member of the Seelos board since 2019.
  • In October 2023, Seelos retained Canaccord Genuity to assist in its ongoing review of potential partnerships, collaborations, and business development opportunities.
  • "We are committed to creating a mental health franchise by aligning with companies having complementary pipelines.
  • We are currently in active discussions with potential partners that align with our strategic vision.

Intra-Cellular Therapies Announces Closing of $575 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Retrieved on: 
onsdag, april 24, 2024
Sale, Prospectus, J.P. Morgan & Co., RBC Capital Markets, Broadridge Financial Solutions, Morgan Stanley, Vesey Street, Canaccord Genuity, Security (finance), SVB Securities, Form S-3, CNS, Form, Exercise, Therapy, Varick Street, Equity capital markets, Cantor, 2nd Floor, State Street, Central nervous system, BofA Securities, Attention, Telephone, File, Needham & Company

All of the shares in the public offering, including the full exercise of the underwriters’ option, were sold by Intra-Cellular Therapies, with gross proceeds to Intra-Cellular Therapies of approximately $575 million, before deducting underwriting discounts and commissions and offering expenses.

Key Points: 
  • All of the shares in the public offering, including the full exercise of the underwriters’ option, were sold by Intra-Cellular Therapies, with gross proceeds to Intra-Cellular Therapies of approximately $575 million, before deducting underwriting discounts and commissions and offering expenses.
  • J.P. Morgan, Leerink Partners, BofA Securities, Morgan Stanley and RBC Capital Markets acted as joint book-running managers for the offering.
  • Cantor, Mizuho, Canaccord Genuity and Needham & Company acted as co-managers for the offering.
  • The public offering was made pursuant to a shelf registration statement on Form S-3 (including a base prospectus) that was previously filed with the Securities and Exchange Commission (the “SEC”) and became effective upon filing.